As acquired resistance ultimately occurs after prolonged exposure of cancer cell lines to specific drugs, a process in which an increase in stem-like cancer cells has been implicated, next, we investigated whether coblockade of EGFR/PARP activity and Notch signalling would postpone or stop the development of drug resistance in vivo. This evidence concerns the gene PARP1 and cancer.